Neurosterix
Founded 2024 · $63.0M raised
- Founded
- 2024
- Website
- neurosterix.com
- Total Funding
- $63.0M
- Last Round
- $63.0M Series AApr 2024
- Rounds
- 1
About
Neurosterix is charting a new path in neuroscience. Founded in 2024, the company is developing next-generation medicines that fine-tune brain signaling with precision, targeting neuropsychiatric disorders that remain among the most urgent and underserved areas of medicine. Current treatments often provide only partial relief, blunting symptoms without restoring healthy brain function, and Neurosterix's work advances neuropsychiatric therapies through allosteric modulation.
Summary
Neurosterix is a Biotech company, founded in 2024. It has raised $63.0M in total across 1 round, most recently a $63.0M Series A round in Apr 2024. Investors include Perceptive Advisors, Perceptive Life Sciences and Acorn Bioventures.
Funding History
Apr 2024
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neurosterix"><img src="https://indexed.vc/api/badge/company/neurosterix" alt="Neurosterix on Indexed.vc" width="260" height="76" /></a>